Mapping the tumor environment in early bladder and breast lesions
A single-cell spatial map characterizing the stromal TME in bladder and breast early-lesions
This study is looking at the early stages of bladder cancer to understand why some patients' cancer comes back but doesn't get worse, while others experience more serious progression, with the goal of helping doctors create more personalized treatment plans for those with early bladder issues.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Methodist Hospital Research Institute NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11074258 on NIH RePORTER |
What this research studies
This research investigates the early stages of bladder cancer by examining the tumor microenvironment at a single-cell level. It aims to understand the mechanisms that either promote or restrain the progression of non-muscle-invasive bladder cancer (NMIBC) to muscle-invasive bladder cancer (MIBC). By identifying biological markers and risk factors, the study seeks to differentiate between patients whose cancer recurs but does not progress and those whose cancer advances. This innovative approach could lead to better risk stratification and personalized treatment strategies for patients with early bladder lesions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with non-muscle-invasive bladder cancer (NMIBC) who are at risk of recurrence.
Not a fit: Patients with muscle-invasive bladder cancer (MIBC) or those without a diagnosis of bladder cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide critical insights that improve the management and treatment of early bladder cancer, potentially leading to better patient outcomes.
How similar studies have performed: While this approach is innovative, similar studies have shown promise in understanding tumor progression in other cancer types, suggesting potential for success in this area as well.
Where this research is happening
Houston, United States
- Methodist Hospital Research Institute — Houston, United States (Active)
Researchers
- Principal investigator: Chan, Keith Syson — Methodist Hospital Research Institute
- Study coordinator: Chan, Keith Syson
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.